U.S. Markets open in 3 hrs 58 mins

Integra LifeSciences upgraded to Buy from Hold at Argus

Argus expects a resolution to Integra LifeSciences' production issues and the clearing of back orders that will result in stronger sales of dermal and wound care products. Price target is $44.